ABBVIE INC (ABBV) Fundamental Analysis & Valuation

NYSE:ABBV • US00287Y1091

Current stock price

205.07 USD
-1.16 (-0.56%)
At close:
206 USD
+0.93 (+0.45%)
After Hours:

This ABBV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ABBV Profitability Analysis

1.1 Basic Checks

  • In the past year ABBV was profitable.
  • In the past year ABBV had a positive cash flow from operations.
  • In the past 5 years ABBV has always been profitable.
  • Each year in the past 5 years ABBV had a positive operating cash flow.
ABBV Yearly Net Income VS EBIT VS OCF VS FCFABBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • ABBV has a better Return On Assets (3.12%) than 88.97% of its industry peers.
  • ABBV has a Return On Invested Capital of 14.42%. This is amongst the best in the industry. ABBV outperforms 96.13% of its industry peers.
  • ABBV had an Average Return On Invested Capital over the past 3 years of 12.12%. This is significantly below the industry average of 19.64%.
  • The 3 year average ROIC (12.12%) for ABBV is below the current ROIC(14.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROIC 14.42%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ABBV Yearly ROA, ROE, ROICABBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

1.3 Margins

  • ABBV's Profit Margin of 6.84% is amongst the best of the industry. ABBV outperforms 89.36% of its industry peers.
  • In the last couple of years the Profit Margin of ABBV has declined.
  • ABBV has a Operating Margin of 34.23%. This is amongst the best in the industry. ABBV outperforms 96.91% of its industry peers.
  • ABBV's Operating Margin has improved in the last couple of years.
  • ABBV has a better Gross Margin (71.62%) than 82.20% of its industry peers.
  • ABBV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
ABBV Yearly Profit, Operating, Gross MarginsABBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. ABBV Health Analysis

2.1 Basic Checks

  • ABBV has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, ABBV has about the same amount of shares outstanding.
  • ABBV has about the same amout of shares outstanding than it did 5 years ago.
  • ABBV has a worse debt/assets ratio than last year.
ABBV Yearly Shares OutstandingABBV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABBV Yearly Total Debt VS Total AssetsABBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • An Altman-Z score of 2.28 indicates that ABBV is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ABBV has a Altman-Z score of 2.28. This is in the better half of the industry: ABBV outperforms 65.38% of its industry peers.
  • The Debt to FCF ratio of ABBV is 3.79, which is a good value as it means it would take ABBV, 3.79 years of fcf income to pay off all of its debts.
  • ABBV has a better Debt to FCF ratio (3.79) than 92.26% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Altman-Z 2.28
ROIC/WACC1.8
WACC8.03%
ABBV Yearly LT Debt VS Equity VS FCFABBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • ABBV has a Current Ratio of 0.67. This is a bad value and indicates that ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of ABBV (0.67) is worse than 89.36% of its industry peers.
  • ABBV has a Quick Ratio of 0.67. This is a bad value and indicates that ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ABBV has a Quick ratio of 0.56. This is amonst the worse of the industry: ABBV underperforms 89.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.56
ABBV Yearly Current Assets VS Current LiabilitesABBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

4

3. ABBV Growth Analysis

3.1 Past

  • The earnings per share for ABBV have decreased by -1.19% in the last year.
  • ABBV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.99% yearly.
  • Looking at the last year, ABBV shows a quite strong growth in Revenue. The Revenue has grown by 8.57% in the last year.
  • The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%

3.2 Future

  • Based on estimates for the next years, ABBV will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.08% on average per year.
  • Based on estimates for the next years, ABBV will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.06%
Revenue Next 2Y9.15%
Revenue Next 3Y8.57%
Revenue Next 5Y6.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ABBV Yearly Revenue VS EstimatesABBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
ABBV Yearly EPS VS EstimatesABBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

7

4. ABBV Valuation Analysis

4.1 Price/Earnings Ratio

  • ABBV is valuated rather expensively with a Price/Earnings ratio of 20.51.
  • 93.23% of the companies in the same industry are more expensive than ABBV, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.23. ABBV is around the same levels.
  • With a Price/Forward Earnings ratio of 13.82, ABBV is valued correctly.
  • ABBV's Price/Forward Earnings ratio is rather cheap when compared to the industry. ABBV is cheaper than 96.33% of the companies in the same industry.
  • ABBV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.51
Fwd PE 13.82
ABBV Price Earnings VS Forward Price EarningsABBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ABBV is valued cheaply inside the industry as 94.39% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, ABBV is valued cheaply inside the industry as 95.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.35
EV/EBITDA 14.59
ABBV Per share dataABBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • ABBV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of ABBV may justify a higher PE ratio.
  • ABBV's earnings are expected to grow with 22.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y28.14%
EPS Next 3Y22.01%

7

5. ABBV Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.07%, ABBV has a reasonable but not impressive dividend return.
  • ABBV's Dividend Yield is rather good when compared to the industry average which is at 1.27. ABBV pays more dividend than 99.03% of the companies in the same industry.
  • ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 3.07%

5.2 History

  • On average, the dividend of ABBV grows each year by 6.76%, which is quite nice.
  • ABBV has paid a dividend for at least 10 years, which is a reliable track record.
  • ABBV has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.76%
Div Incr Years11
Div Non Decr Years11
ABBV Yearly Dividends per shareABBV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • ABBV pays out 278.48% of its income as dividend. This is not a sustainable payout ratio.
  • ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP278.48%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
ABBV Yearly Income VS Free CF VS DividendABBV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
ABBV Dividend Payout.ABBV Dividend Payout, showing the Payout Ratio.ABBV Dividend Payout.PayoutRetained Earnings

ABBV Fundamentals: All Metrics, Ratios and Statistics

ABBVIE INC

NYSE:ABBV (3/20/2026, 8:04:00 PM)

After market: 206 +0.93 (+0.45%)

205.07

-1.16 (-0.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-23
Inst Owners76.17%
Inst Owner Change2.22%
Ins Owners0.06%
Ins Owner Change6.1%
Market Cap362.60B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.44
Price Target255.68 (24.68%)
Short Float %1.24%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield 3.07%
Yearly Dividend6.6
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years11
Div Non Decr Years11
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)1.25%
PT rev (3m)2.85%
EPS NQ rev (1m)0.56%
EPS NQ rev (3m)-1.6%
EPS NY rev (1m)2.19%
EPS NY rev (3m)2.16%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)-1.02%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 20.51
Fwd PE 13.82
P/S 5.93
P/FCF 20.35
P/OCF 19.05
P/B N/A
P/tB N/A
EV/EBITDA 14.59
EPS(TTM)10
EY4.88%
EPS(NY)14.84
Fwd EY7.24%
FCF(TTM)10.08
FCFY4.91%
OCF(TTM)10.76
OCFY5.25%
SpS34.59
BVpS-1.85
TBVpS-51.78
PEG (NY)0.42
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROCE 23.09%
ROIC 14.42%
ROICexc 15.28%
ROICexgc N/A
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
FCFM 29.13%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Debt/EBITDA 2.11
Cap/Depr 14.92%
Cap/Sales 1.98%
Interest Coverage 6.97
Cash Conversion 65.45%
Profit Quality 425.61%
Current Ratio 0.67
Quick Ratio 0.56
Altman-Z 2.28
F-Score8
WACC8.03%
ROIC/WACC1.8
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.15%
Revenue Next 3Y8.57%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.07%
EBIT Next 3Y19.5%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%

ABBVIE INC / ABBV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ABBVIE INC?

ChartMill assigns a fundamental rating of 5 / 10 to ABBV.


What is the valuation status of ABBVIE INC (ABBV) stock?

ChartMill assigns a valuation rating of 7 / 10 to ABBVIE INC (ABBV). This can be considered as Undervalued.


Can you provide the profitability details for ABBVIE INC?

ABBVIE INC (ABBV) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ABBV stock?

The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 20.51 and the Price/Book (PB) ratio is -110.89.


What is the expected EPS growth for ABBVIE INC (ABBV) stock?

The Earnings per Share (EPS) of ABBVIE INC (ABBV) is expected to grow by 48.4% in the next year.